免疫系统
先天免疫系统
生物
表观遗传学
串扰
代谢途径
炎症
免疫学
肺动脉高压
细胞生物学
免疫失调
内皮
癌症研究
生物信息学
重编程
获得性免疫系统
细胞代谢
脂质代谢
医学
经典补体途径
内皮功能障碍
信号转导
补体系统
小RNA
细胞代谢
缺氧(环境)
血管生成
免疫
作者
Jianli Ma,Xiyu Cao,Xiuli Yang,Yi Zhu,Hao Wang,Yundou Liu,Ke Chen,Xiao Liu,Chuantao Zhang
标识
DOI:10.3389/fphar.2025.1712903
摘要
Pulmonary hypertension (PH) is a clinical syndrome characterized by progressive elevation of pulmonary vascular resistance, whose pathological process is closely related to the crosstalk between immune dysregulation and metabolic remodeling, forming a complex immune-metabolic regulatory network. The abnormal activation and polarization of innate immune cells, as well as the imbalance and autoreactivity of the adaptive immune system, jointly drive the pulmonary vascular inflammatory response. Metabolic reprogramming of pulmonary artery smooth muscle cells, pulmonary artery endothelial cells, and others provides the energy and material basis for abnormal proliferation of vascular cells. Abnormal products generated by metabolic disorders can regulate energy metabolism of immune cells and inflammatory signals; abnormal activation of immune signals can remodel metabolic pathways. The two interact through mechanisms such as the mitochondria-inflammasome axis and epigenetic regulation, collectively promoting vascular remodeling. Targeting this network, natural products exhibit unique advantages due to their characteristics of multiple components and multiple targets. Among them, immunomodulatory natural products can improve the immune microenvironment by inhibiting core inflammatory pathways and regulating immune cell infiltration. Metabolic regulatory natural products focus on restoring mitochondrial function and correcting abnormal glucose and lipid metabolism to interfere with metabolic remodeling. By targeting mTOR, SIRT1 and other pivotal molecules, immune metabolic dual regulatory natural products can synchronously regulate immune response and metabolic activities, and block the vicious cycle of immune activation, metabolic disorder and vascular remodeling. However, challenges remain, including insufficient mechanistic depth and a significant gap between preclinical models and clinical application. Further research into these mechanisms may provide novel insights for PH therapy and improve patient prognosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI